Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 78
Optical 76
Immune Disorders Drugs 74
Optical Disorders Drugs 67
Cardiovascular Drugs 43
Musculoskeletal Disorders Drugs 38
Biopharmaceuticals 37
Drug Discovery 36
Dermatological Drugs 36
Biotechnology 33
Genomics 26
Clinical Trials 20
Endocrine and Metabolic Disorders Drugs 20
Allergy and Immunology 18
Central Nervous System Drugs 18
Pharmaceuticals 18
Skin Cancer Drugs 18
Infectious Diseases Drugs 16
Drugs by Therapeutic Area 14
Respiratory Drugs 14
Infusions and Injectables 13
Lung Cancer Drugs 12
Allergy Drugs 12
Dermatology 10
Gastrointestinal Drugs 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Diagnostics 7
Needles and Syringes 7
Enzymes 6
Vaccines 6
Biosimilars and Biosuperiors 6
Asthma Drugs 6
Pharmaceutical Manufacturing 6
Prostate Cancer Drugs 5
Drug Delivery 5
Gastroenterology 5
Therapeutic Area 4
Pulmonary Medicine 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Immunosuppressive Drugs 4
Company Reports 3
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Lymphoma Drugs 3
Colon Cancer Drugs 3
Brain Cancer Drugs 3
Cardiovascular Devices 3
Analgesics 3
Medical Devices 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Neurology 2
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Laboratory Equipment 2
Pediatrics 2
Cardiology 2
Hepatology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Palliative Care 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



287 reviews

654 Results (Page 7 of 33)
- Relevance
  Sort by

Vascular Endothelial Growth Factor (Vegf) Inhibitors Market 2024-2028

 Report
May 2024
178 Pages
Global

From

€2322EUR$2,500USD£1,943GBP

Atopic Dermatitis (Atopic Eczema) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

 Report
September 2023
1105 Pages
Global

From

€2322EUR$2,500USD£1,943GBP

Thyroid Eye Disease Treatments Market - Global Forecast 2026-2032

 Report
September 2026
188 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

Retinal Biologics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

 Report
January 2024
255 Pages
Global

From

€2322EUR$2,500USD£1,943GBP

Ankylosing Spondylitis Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4171EUR$4,490USD£3,489GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Chronic Kidney Disease - Competitive Landscape and Clinical Trial Analysis, 2026

 Report
September 2026
280 Pages
Global

From

€2787EUR$3,000USD£2,331GBP

Systemic Lupus Erythematosus Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€4171EUR$4,490USD£3,489GBP

Macular Degeneration Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

 Report
January 2026
131 Pages
Global

From

€4412EUR$4,750USD£3,691GBP

Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
162 Pages
Global

From

€1858EUR$2,000USD£1,554GBP

Atopic Dermatitis Drugs Market - Global Forecast 2026-2032

 Report
September 2026
192 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

Chromatography Consumables and Chromatography Instrumentation Market: Distribution by Type of Product, Type of Chromatography Instruments, Type of Consumable Formats, End Users and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

 Report
August 2023
215 Pages
Global

From

€4458EUR$4,799USD£3,729GBP

Diabetic Macular Edema Treatment Market - Global Forecast 2026-2032

 Report
September 2026
185 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

Choroidal Neovascularization Market Report by Product Type, Diagnosis, Treatment Type, Application, and Region 2026-2034

 Report
April 2026
144 Pages
Global

From

€3715EUR$3,999USD£3,108GBP

Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2026-2034

 Report
April 2026
149 Pages
Global

From

€3715EUR$3,999USD£3,108GBP

Myopia & Presbyopia Treatment Market - Global Forecast 2026-2032

 Report
September 2026
195 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

 Report
December 2023
137 Pages
Global

From

€2299EUR$2,475USD£1,923GBP

€4598EUR$4,950USD£3,847GBP

Global CD3 Antibodies Market, Dosage, Price, Sales & Clinical Trials Insight 2028

 Report
October 2023
470 Pages
Global

From

€2601EUR$2,800USD£2,176GBP

Fully Humanized Antibody Market - Global Forecast 2026-2032

 Report
September 2026
190 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

Recombinant Humanized Bisspecific Antibody Market - Global Forecast 2026-2032

 Report
September 2026
187 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

Interleukin-6 Inhibitors for Rheumatoid Arthritis Market - Global Forecast 2026-2032

 Report
September 2026
181 Pages
Global

From

€3293EUR$3,545USD£2,755GBP

€3659EUR$3,939USD£3,061GBP

654 Results (Page 7 of 33)
- 1
- 5
- 6
- 7
- 8
- 9

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.